Main Article Content
Abstract
Metabolic Syndrome is a constellation of several factors like hyperglycemia, raised blood pressure, insulin resistance, dyslipidemia, and central obesity. Among these factors central obesity & insulin resistance are the dominant parameters of this collection. In today’s era its prevalence is rising rapidly and it has a high socioeconomic burden. Being the major risk factor for Cardio Vascular Disease and Type 2 Diabetes Mellitus, it is the need of the hour to find a safe and cost effective remedy for Metabolic Syndrome. Santarpana Nimittaj Vikara in Ayurvedic Classics can be correlated to Metabolic Syndrome and Virechana Karma is an effective measure which helps in cleansing congested Strotas and removing vitiated Dosha hence pacifying the symptoms of Metabolic Syndrome. Patients of either sex in the age group of 20 to 60 years, fulfilling the study criteria were included in the study. Two sittings of Virechana Karma were administered with 15 day gap in between. Highly significant in all criteria except Blood sugar fasting. Conclusion: Virechana Karma is an ideal therapy for Metabolic Syndrome
Keywords
Metabolic Syndrome
Virechana Karma
Santarpana Nimittaj Vikara
Dosha
Strota
Type 2 Diabetes Mellitus
Article Details
License
Copyright (c) 2019 (C) ASEA
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Sharma, . P., Srivastava , A., Tiwari, . S. K., & Shukla, . G. D. (2019). Role of virechana karma in metabolic syndrome- Clinical trial. Environment Conservation Journal, 20(SE), 25–29. https://doi.org/10.36953/ECJSE.2019.02005
References
-
Balkau, B., Vernay, M., Mhamdi, L., Novak, M., Aronde, D. and Vol, S. 2003. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French DESIR study. Diabetes & Metabolism, 29(5):526–532.
Chaudhary Nidhi 2017c. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 73.
Chaudhary Nidhi, 2017a. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 68.
Chaudhary Nidhi, 2017b. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 71.
Expert Panel on Detection, Evaluation THBCA: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J-AM MED ASSOC 2001, 285(19):2486–2497.
Ford, E.S., Giles, W.H. and Dietz, W.H. 2002. Prevalence of the metabolic syndrome among US adults. JAMA: J Am Med Assoc, 287(3): 356–359.
Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H. and Franklin, B.A. 2005. Diagnosis and management of the metabolic syndrome. Circulation 112(17):2735–2752.
Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V. and Kothari, K. 2003. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract, 61(1): 69–76.
Meigs, J.B. 2000. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol, 152(10):908–911.
Meigs, J.B. 2002. Epidemiology of the metabolic syndrome, Am J Managed Care 8(11), SUPP/1): 283–292.
Miranda, P.J., DeFronzo, R.A., Califf, R.M. and Guyton, J.R. 2005. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J, 149(1): 33-45.
Ramachandran, A., Snehlata, C., Satyavani, K., Sivasankari, S. and Vijay, V. 2003. Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res Clin Pract, 60(3):199–204.
Shastri Datta Rajeshwara, 2009a. Upadhyaya Yadunandan, Pandeya Sahaya Ganga, and Gupta Dasa Banarasi, Mishra Brahmashankara (editors) Commentary: Vidhyotani teka of Kasi Nath Sastri & Gorakha Nath Chaturvedi of Charak Samhita of Agnivesha, Sutrasthan, chapter 23, verse no. 8, Varanasi: Chaukhambha Bharti Academy:437.
Shastri Datta Rajeshwara, 2009b. Upadhyaya Yadunandan, Pandeya Sahaya Ganga, and Gupta Dasa Banarasi, Mishra Brahmashankara (editors) Commentary: Vidhyotani teka of Kasi Nath Sastri & Gorakha Nath Chaturvedi of Charak Samhita of Agnivesha, Siddhisthan, chapter 2, verse no.13 , Varanasi: Chaukhambha Bharti Academy:981.
Tiwari K Shashi (2018). Characterization of the urine of patients of Metabolic Syndrome and Prediabetics and its correlation with Different Types of Prameha: Review of Ayurvedic Literature, PhD Thesis, Dept. of Vikriti Vigyana, I.M.S., B.H.U., Varanasi: 5.
References
Balkau, B., Vernay, M., Mhamdi, L., Novak, M., Aronde, D. and Vol, S. 2003. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French DESIR study. Diabetes & Metabolism, 29(5):526–532.
Chaudhary Nidhi 2017c. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 73.
Chaudhary Nidhi, 2017a. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 68.
Chaudhary Nidhi, 2017b. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 71.
Expert Panel on Detection, Evaluation THBCA: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J-AM MED ASSOC 2001, 285(19):2486–2497.
Ford, E.S., Giles, W.H. and Dietz, W.H. 2002. Prevalence of the metabolic syndrome among US adults. JAMA: J Am Med Assoc, 287(3): 356–359.
Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H. and Franklin, B.A. 2005. Diagnosis and management of the metabolic syndrome. Circulation 112(17):2735–2752.
Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V. and Kothari, K. 2003. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract, 61(1): 69–76.
Meigs, J.B. 2000. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol, 152(10):908–911.
Meigs, J.B. 2002. Epidemiology of the metabolic syndrome, Am J Managed Care 8(11), SUPP/1): 283–292.
Miranda, P.J., DeFronzo, R.A., Califf, R.M. and Guyton, J.R. 2005. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J, 149(1): 33-45.
Ramachandran, A., Snehlata, C., Satyavani, K., Sivasankari, S. and Vijay, V. 2003. Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res Clin Pract, 60(3):199–204.
Shastri Datta Rajeshwara, 2009a. Upadhyaya Yadunandan, Pandeya Sahaya Ganga, and Gupta Dasa Banarasi, Mishra Brahmashankara (editors) Commentary: Vidhyotani teka of Kasi Nath Sastri & Gorakha Nath Chaturvedi of Charak Samhita of Agnivesha, Sutrasthan, chapter 23, verse no. 8, Varanasi: Chaukhambha Bharti Academy:437.
Shastri Datta Rajeshwara, 2009b. Upadhyaya Yadunandan, Pandeya Sahaya Ganga, and Gupta Dasa Banarasi, Mishra Brahmashankara (editors) Commentary: Vidhyotani teka of Kasi Nath Sastri & Gorakha Nath Chaturvedi of Charak Samhita of Agnivesha, Siddhisthan, chapter 2, verse no.13 , Varanasi: Chaukhambha Bharti Academy:981.
Tiwari K Shashi (2018). Characterization of the urine of patients of Metabolic Syndrome and Prediabetics and its correlation with Different Types of Prameha: Review of Ayurvedic Literature, PhD Thesis, Dept. of Vikriti Vigyana, I.M.S., B.H.U., Varanasi: 5.
Chaudhary Nidhi 2017c. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 73.
Chaudhary Nidhi, 2017a. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 68.
Chaudhary Nidhi, 2017b. Clinical evaluation of Virechana in management of Metabolic Syndrome, MD Thesis; Dept. of Panchakarma; Rishikul campus; UAU: 71.
Expert Panel on Detection, Evaluation THBCA: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J-AM MED ASSOC 2001, 285(19):2486–2497.
Ford, E.S., Giles, W.H. and Dietz, W.H. 2002. Prevalence of the metabolic syndrome among US adults. JAMA: J Am Med Assoc, 287(3): 356–359.
Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H. and Franklin, B.A. 2005. Diagnosis and management of the metabolic syndrome. Circulation 112(17):2735–2752.
Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V. and Kothari, K. 2003. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract, 61(1): 69–76.
Meigs, J.B. 2000. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol, 152(10):908–911.
Meigs, J.B. 2002. Epidemiology of the metabolic syndrome, Am J Managed Care 8(11), SUPP/1): 283–292.
Miranda, P.J., DeFronzo, R.A., Califf, R.M. and Guyton, J.R. 2005. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J, 149(1): 33-45.
Ramachandran, A., Snehlata, C., Satyavani, K., Sivasankari, S. and Vijay, V. 2003. Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res Clin Pract, 60(3):199–204.
Shastri Datta Rajeshwara, 2009a. Upadhyaya Yadunandan, Pandeya Sahaya Ganga, and Gupta Dasa Banarasi, Mishra Brahmashankara (editors) Commentary: Vidhyotani teka of Kasi Nath Sastri & Gorakha Nath Chaturvedi of Charak Samhita of Agnivesha, Sutrasthan, chapter 23, verse no. 8, Varanasi: Chaukhambha Bharti Academy:437.
Shastri Datta Rajeshwara, 2009b. Upadhyaya Yadunandan, Pandeya Sahaya Ganga, and Gupta Dasa Banarasi, Mishra Brahmashankara (editors) Commentary: Vidhyotani teka of Kasi Nath Sastri & Gorakha Nath Chaturvedi of Charak Samhita of Agnivesha, Siddhisthan, chapter 2, verse no.13 , Varanasi: Chaukhambha Bharti Academy:981.
Tiwari K Shashi (2018). Characterization of the urine of patients of Metabolic Syndrome and Prediabetics and its correlation with Different Types of Prameha: Review of Ayurvedic Literature, PhD Thesis, Dept. of Vikriti Vigyana, I.M.S., B.H.U., Varanasi: 5.